News topic
Clinical Trials News & Updates
Ongoing and completed clinical trial coverage — enrollment, interim readouts, and published endpoints.
3 articles in this topic
Clinical Trials2026-02-20 6 min
Retatrutide Phase 3: Triple Agonist Delivers 71 lbs Average Weight Loss
Eli Lilly's triple-agonist retatrutide delivered an average 71.2 lbs of weight loss in the TRIUMPH-4 Phase 3 trial — plus significant osteoarthritis pain relief. Seven more Phase 3 trials report in 2026.
Clinical Trials2026-02-28 4 min
Tirzepatide 3-Year Data: Weight Loss Sustained at 22.9%
The SURMOUNT-1 three-year extension confirms what patients needed to know: tirzepatide weight loss holds steady through year 3 with continued treatment.
Clinical Trials2026-04-08 7 min
Tirzepatide for Sleep Apnea: SURMOUNT-OSA Trial Shows Dramatic Results
The SURMOUNT-OSA trial demonstrated that tirzepatide reduced obstructive sleep apnea severity by up to 63%, with some patients achieving complete remission — potentially transforming treatment for 30+ million Americans.